Lunch Program: Advanced Coronary Intervention: Integrating IVUS and DCB Therapy for Precision and Performance.
Sponsored by Boston Scientific.
In this session, faculty will present the latest evidence on the AGENT™ Coronary Drug-Coated Balloon and demonstrate how intravascular ultrasound (IVUS) can refine technique, enhance precision, and optimize procedural results. Attendees will advance their expertise and elevate their practice with review of clinical data, challenging case dissection, and examples of how to leverage IVUS.